Back to Journals » Drug Design, Development and Therapy » Volume 17

Letter

Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter]

       
Total article views   HTML views PDF downloads Totals
2,566 Dovepress* 2,477+ 60 2,537
PubMed Central* 89 40 129
Totals 2,566 100 2,666
*Since 5 February 2023

View citations on PubMed Central and Google Scholar